Skip to main content Skip to footer

Teun Petersen

College positions:
Affiliated Postdoctoral Member
Subject:
Biostatistics
Department/institution:
MRC Biostatistics Unit - University of Cambridge

Dr Teun Petersen

Dr Teun Petersen is a Research Associate at the MRC Biostatistics Unit, University of Cambridge. He obtained his PhD in Biostatistics & Epidemiology from the Erasmus University Medical Center in Rotterdam, the Netherlands. Prior to his doctoral studies, he earned his MSc and BSc (Cum Laude) in Econometrics and Operations Research from the University of Amsterdam.

During his PhD, Dr Petersen’s research focused on dynamic risk prediction and biomarker discovery for heart failure in high-dimensional longitudinal settings, utilizing advanced statistical and machine learning methods. He investigated how plasma protein profiles can identify subphenotypes in patients with heart failure with reduced ejection fraction, revealing that these are driven by distinct biological mechanisms. Alongside his research, he served as a statistical consultant at the Erasmus MC, advising various clinical departments on study design, statistical software, and complex methodological questions.

Dr Petersen joined the University of Cambridge in March 2025. His current work entails understanding clinical risk prediction in heart failure using electronic health records. Specifically, he is focusing on decomposing the role of uncertainty within these predictions, and exploring how to utilize value of information and personalized risk profiles to optimally schedule patient follow-up visits. In his free time he enjoys dancing salsa, going to festivals, and finding the perfect cup of coffee.

Select publications

  • Teun B. Petersen, Eric Boersma, Isabella Kardys, and Dimitris Rizopoulos. Risk-profile based monitoring intervals for multivariate longitudinal biomarker measurements and competing events with applications in stable heart failure. Statistics in Medicine, 44(10-12):e70088, May 2025.
  • Teun B. Petersen, Marie de Bakker, Folkert W. Asselbergs, Magdalena Harakalova, K. Martijn Akkerhuis, Jasper J. Brugts, Jan van Ramshorst, R. Thomas Lumbers, Rachel M. Ostroff, Peter D. Katsikis, Peter J. van der Spek, Victor A. Umans, Eric Boersma, Dimitris Rizopoulos, and Isabella Kardys. HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms. EBioMedicine, 93, July 2023.
  • Marion van Vugt, Ruicong She, Isabella Kardys, Teun B Petersen, Marie de Bakker, K Martijn Akkerhuis, Kadir Caliskan, Olivier C Manintveld, Alicia Uijl, Jan van Ramshorst, Dimitris Rizopoulos, Victor Awm Umans, Eric Boersma, David E Lanfear, Folkert W Asselbergs, Jessica van Setten, and A Floriaan Schmidt. Proteomics-based clustering outperforms clinical clustering in identifying people with heart failure with distinct outcomes. Commun Med (Lond), 5(1):505, November 2025.
  • Marie de Bakker, Teun B. Petersen, Anja J. Rueten-Budde, K. Martijn Akkerhuis, Victor A. Umans, Jasper J. Brugts, Tjeerd Germans, Marcel J.T. Reinders, Peter D. Katsikis, Peter J. van der Spek, Rachel Ostroff, Ruicong She, David Lanfear, Folkert W. Asselbergs, Eric Boersma, Dimitris Rizopoulos, and Isabella Kardys. Machine learning–based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure. European Heart Journal – Digital Health, 4(6):444–454, December 2023.
  • Teun B. Petersen, Dimitris Rizopoulos, Eric Boersma, Florence Pinet, Isabella Kardys, and Christophe Bauters. Plasma proteins and mechanisms involved in the evolvement of cardiac function after myocardial infarction. Scientific Reports 16, 13251, March 2026.
  • Teun B. Petersen, Mylène Barry-Loncq de Jong, Jie Fen Chin, Navin Suthahar, Peter J. van der Spek, Peter D. Katsikis, K. Martijn Akkerhuis, Victor A. Umans, Rudolf A. de Boer, Bas M. van Dalen, Jasper J. Brugts, Folkert W. Asselbergs, Eric Boersma, Dimitris Rizopoulos, Sing-Chien Yap, and Isabella Kardys. Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction. Heart Rhythm O2, June 2025.
  • Teun B. Petersen, Navin Suthahar, Folkert W. Asselbergs, Marie de Bakker, K. Martijn Akkerhuis, Alina A. Constantinescu, Jan van Ramshorst, Peter D. Katsikis, Peter J. van der Spek, Victor A. Umans, Rudolf A. de Boer, Eric Boersma, Dimitris Rizopoulos, and Isabella Kardys. Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcome. Obesity, 32(9):1658–1669, September 2024.

Further links

MRC Biostatistics Unit – https://www.mrc-bsu.cam.ac.uk/staff/teun-petersen
ORCID – https://orcid.org/0000-0002-2338-9931
Google Scholar – https://scholar.google.com/citations?user=NHumZlYAAAAJ
LinkedIn – https://www.linkedin.com/in/teun/